Next Article in Journal
In Vitro Cytotoxicity Evaluation of Plastoquinone Analogues against Colorectal and Breast Cancers along with In Silico Insights
Previous Article in Journal
Structure-Guide Design and Optimization of Potential Druglikeness Inhibitors for TGFβRI with the Pyrrolopyrimidine Scaffold
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Chemistry and Bioactivities of Six Tunisian Eucalyptus Species

1
Faculty of Sciences, Bizerte, Zarzouna 7021, Tunisia
2
Laboratory of Biotechnology and Nuclear Technology, National Center of Nuclear Science and Technology, Sidi Thabet, B.P. 72, Ariana 2020, Tunisia
3
Department of Pharmacy, University of Salerno, Via San Giovanni Paolo II, 132, 84084 Fisciano, Italy
4
Laboratory of Management and Valorization of Forest Resources, National Institute of Researches on Rural Engineering, Water and Forests, P.B. 10, Ariana 2080, Tunisia
5
Institute of Food Science, CNR-ISA, Via Roma, 64, 83100 Avellino, Italy
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Pharmaceuticals 2022, 15(10), 1265; https://doi.org/10.3390/ph15101265
Submission received: 27 September 2022 / Revised: 10 October 2022 / Accepted: 10 October 2022 / Published: 14 October 2022
(This article belongs to the Topic Bioactive Phytochemicals from Plant Essential Oils)

Abstract

:
The complex taxonomy of Eucalyptus genus, the renewed interest in natural compounds able to combat microbial strains, the overuse of synthetic pesticides, the consequent request for alternative control methods were the reasons for this research. The essential oils (Eos) of Eucalyptus bosistoana, Eucalyptus melliodora, Eucalyptus odorata, Eucalyptus paniculata, Eucalyptus salmonopholia, and Eucalyptus transcontinentalis were analyzed by GC/MS and their potential phytotoxic activity was evaluated against the germination and radicle elongation of Sinapis arvensis, Raphanus sativus and Lolium multiflorum. The antibiofilm activity was assayed against both Gram-positive (Staphylococcus aureus and Listeria monocytogenes) and Gram-negative (Pseudomonas aeruginosa, Escherichia coli, and Acinetobacter baumannii) bacteria. Monoterpenoids were the most representative constituents in all EOs and eucalyptol was the dominant component except in E. melliodora EO, in which p-cymene was the most abundant. In phytotoxic assays, the EOs from E. odorata and E. paniculata were the most active against germination and radical elongation of the tested seeds. Finally, the Eucalyptus EOs proved their capacity to effectively inhibit the adhesion process of all five pathogen strains, with percentages often reaching and exceeding 90%. These Eucalytpus EOs could have possible employments in the food, health and agricultural fields.

Graphical Abstract

1. Introduction

In 1788, the term eucalyptus, which means ‘well covered’, was coined by the French botanist, Charles Louis L’Héritier de Brutelle, referring to a genus with the operculate nature of the flower which lacks conspicuous petals and sepals [1].
Native to Australia, the genus Eucalyptus (Myrtaceae family) contains about 900 species and subspecies [2]. It has spread worldwide, particularly in Africa, because of its easy adaptability and fast growth [3] and it is now extensively cultivated in many countries for several applications such as cellulose, pulp, gum, essential oils, and honey production, as well as for construction and as an ornamental plant [4].
In order to improve the forest production, great efforts of reforestation based on Eucalyptus L’Hér species were implemented in Tunisia [3], where 117 species have been introduced. They were used as fire wood, for the production of mine wood, and in the fight against erosion [5].
Eucalyptus are woody perennial plants, varying from shrubs to tall trees: they can reach gigantic size and are mostly evergreen [6]. Eucalyptus species show leaf dimorphism: the juvenile leaves are opposite, oval to roundish, occasionally sessile and glaucous; mature leaves are alternate, entire, petiolate, lanceolate/elliptical/oblong/oval, often thick, stiff, highly cutinized and coriaceous [7]. Different types of inflorescence are observed within the species, axillary, umbel, cymes, panicles and corymbs; only in E. globulus Labill. solitary flowers are present. Fruits are woody capsule with seeds >1 mm to <2 cm in size, spherical, cuboid, elliptical, yellow to black colored [8].
Eucalyptus genus has a very complex taxonomic history. Different scholars have classified this genus and proposed various taxonomic positions time to time [6]: Brooker classified and combined Eucalyptus L’Hér. with Angophora Cav. and Corymbia Hill & Johnson in a single genus, Eucalyptus, but later several molecular studies and advanced phylogenetic analysis provided sufficient evidence to recognize both Angophora and Corymbia as separate genera [6].
The main products obtained from Eucalyptus are essential oils (EOs) [9], particularly employed for their antimicrobial [10], antifungal [11], antiseptic [12], wound healing, disinfectant [13] and phytotoxic abilities [2].
The leaves of over 300 species in this genus produce volatile oil [14]. The pharmaceutical and cosmetic industries have economically exploited only 20 species of Eucalyptus EOs rich in eucalyptol [15].
In recent years, the renewed interest in natural compounds is mainly due to those employed to combat microbial strains, exhibiting resistance to pharmacological substances [16]. Drug resistance develops among Gram-negative bacteria such as Escherichia coli and Pseudomonas aeruginosa, as well as Gram-positive bacteria like Staphylococcus aureus [17]. Different scientific works reported antimicrobial properties of the EOs from Eucalyptus leaves [18,19]. In particular, the antibacterial activity of the essential oils from leaves of E. globulus and E. camaldulensis Dehnh. was investigated against E. coli and S. aureus [20]. However, their ability to fight against the immature and mature biofilms of Gram-positive and Gram-negative bacteria, which allow for an increase of their virulence and a consequent greater resistance to conventional antibiotics, is poorly explored [21].
The current overuse of synthetic agrochemicals, causing environment and human health problems and pesticide-resistant biotypes, the onset of resistance phenomena and the agrochemicals’ withdrawal and restrictions (Directive 91/414/EEC, July 1993 and Regulation 1107/2009/EC, 2011) on a European and worldwide scale, are encouraging a decrease in their use and the need for alternative and “green” control methods [22].
Volatile allelochemicals derived from eucalyptus oils demonstrated also herbicidal activity against many weed species: specifically, volatile oils from E. citriodora Hook. and E. nicholii Maiden & Blakely showed phytotoxic effects, respectively, against hairy beggarticks (Bidens pilosa L.), green amaranth (Amaranthus viridis L.), nepal dock (Rumex nepalensis Spreng.) and wild tamarind [Leucaena leucocephala (Lam.) de Wit] [23], and against redroot pigweed (Amaranthus retroflexus L.), purslane (Portulaca oleracea L.) and Russian knapweed (Acroptilon repens (L.) DC) [24].
Other eucalyptus oils have also shown antigerminative effects [18], thus suggesting their possible further use as natural herbicides.
Nevertheless, the phytotoxic activity of eucalyptus oils can also cause damage to some crops, so the focus of the research is on the discovery of new selective herbicides in which the effect against weeds is maximized and towards crops is reduced.
Therefore, the variability of species in the Eucalyptus genus, its complex taxonomy, and the renewed focus on new natural antibacterial and herbicidal compounds were the reasons for conducting this research. The goals were (1) to study the variations in chemical compositions of the EOs from the leaves of Tunisian Eucalyptus bosistoana F. Muell., E. melliodora A. Cunn. ex Schauer, E. odorata Behr, E. paniculata Sm., E. salmonopholia F. Muell., and E. transcontinentalis Maiden; (2) to examine their potential phytotoxic activity and inhibitory effects against pathogenic biofilm.

2. Results

The hydrodistillation furnished pale yellow essential oils with variable yields: 1.0, 1.3, 0.6, 0.1, 3.0, and 1.6%, respectively, for E. bosistoana, E. melliodora, E. odorata, E. paniculata, E. salmonopholia, and E. transcontinentalis.

2.1. Chemical Composition of Essentials Oils

Table 1 reports the composition of the EOs. One hundred and four components were identified: the highest number (39) was identified in E. bosistoana EO; conversely, only 16 components have been detected in E. melliodora EO. Eucalyptol was the main component of all EOs (except E. odorata EO), with a percentage ranging between 44.9 (E. paniculata EO) and 78.1% (E. melliodora EO). α-Pinene was the second main component in E. transcontinentalis EO (14.8%), E. salmonopholia EO (10.9%) and E. melliodora EO (8.2%). trans-Pinocarveol is the second main compound of the oils of E. bosistoana (6.8%) and E. paniculata (10.8%). In E. odorata EO, p-cymene represented the main component (25.4%), followed by neo-verbanol (7.9%). Monoterpenoids were the main components in all EOs, mainly represented by oxygenated ones, ranging between 62.7 (E. odorata EO) and 89.0% (E. melliodora EO). Sesquiterpenoids ranged between 14.9 (in E. salmonopholia EO) and 13.0% (in E. paniculata EO), while they were absent in E. melliodora EO.
In 1987, Holeman and coworkers [25] found an E. bosistoana EO with a different chemotype, in which α-terpineol was the main component. Bouzabata and coworkers [26] also studied the composition and the chemical variability of eight EOs of E. bosistoana from Algerian Sahara, dividing the samples in two groups: in the first group, p-cymene was the dominant component; in the second group, as in sample here reported, high percentages of eucalyptol, ranging between 55.3 and 63.9%, were present. E. bosistoana and E. melliodora EOs, distilled from plants growing in Morocco region, had a chemical composition similar to our samples [27]. The compositions of EOs distilled from Tunisian E. bosistoana and E. melliodora were already reported in literature: Ameur and coworkers [14] found eucalyptol and α-pinene as the main components in both oils. These results partially confirmed the data reported in this work.
An EO from E. melliodora plants growing in Rwanda was reported by Umereweneza and coworkers [1] with a composition similar to the EO studied in this paper: eucalyptol and α-pinene were the most abundant components together with aromadendrene, not found in the studied sample. Sadeghi et al. [28] found an EO from E. melliodora with a similar composition: the authors reported eucalyptol and α-pinene with percentages of 51.1 and 9.5%, respectively. On the other hand, Eid and coworkers [29] reported a different constitution of an E. melliodora EO, with p-cymene (30.04%) and spathulenol (25.09%) as the predominant components.
The composition of E. salmonopholia essential oil was not previously reported in literature.
Elaissi et al. [5,30,31] reported chemical constitutions of an EO from E. odorata quite different from our data, with the ketone cryptone and p-cymene as the main components and a low amount of oxygenated monoterpenes.
However, the same authors [32] reported the composition of an E. paniculata EO with higher amounts (89.8%) of oxygenated components, first of all sesquiterpenes alcohols (τ-cadinol and 7-epi-α-eudesmol), sesquiterpenes oxides (caryophyllene oxide) and monoterpene oxides (eucalyptol). Dorsaf and coworkers [3] inferred the chemical characterization of a Tunisian EO from E. transcontinentalis; also in this case, the results displayed eucalyptol as the main component followed by α-pinene. Elaissi et al. [33] reported the composition of the EOs from several Eucalyptus species harvested in Tunisia, including E. transcontinentalis. This EO was characterized by a high amount of eucalyptol, followed by viridiflorol; in general, the results showed that the EO was rich in oxygenated sequiterpenes.

2.2. Phytotoxic Activity

The phytotoxic effects of the EOs, tested on germination and radical elongation of Raphanus sativus L. cv ‘Saxa’, Sinapis arvenisis L. and Lolium multiflorum Lam, were reported in Table 2.
The germination and radical elongation of radish were significantly inhibited by all doses of E. bosistoana, E. odorata, and E. paniculata EOs. Other EOs showed significant inhibitory effects on radish germination in the following order: E. transcontinentalis > E. salmonopholia > E. melliodora; whereas for the significant inhibitory effect of radish radical elongation the order was E. transcontinentalis > E. melliodora > E. salmonopholia.
The EO from E. odorata completely inhibited the germination of S. arvensis, at all doses tested. E. paniculata was the second most active oil; in fact, at the lowest doses tested, the inhibition of germination was 82.8% and the inhibition of radical elongation was 79.3%. The other EOs showed inhibition of germination >50% only at the two highest doses used. The EO of E. salmonopholia was the less active on radical growth of S. arvensis, while the other three oils showed inhibition of radical elongation of more than 50%, at all doses tested.
Only E. odorata and E. paniculata EOs totally inhibited the germination of L. multiflorum, at the highest doses tested. In the same case, E. salmonopholia and E. melliodora EOs seemed the less active EOs, with an inhibition of germination of 20.7 and 24%, respectively, at the highest doses tested. All other EOs (except E. salmonopholia) inhibited in a significant way the radical elongation of the seeds at all doses tested.
Recently, our research group reported the phytotoxicity and eco-compatibility of essential oils from Eucalyptus gunnii Hook. f. and E. pulverulenta Sims ‘Baby Blue’ cultivated in Italy [4]. The oils were tested on weeds (L. multiflorum Lam. and Portulaca oleracea L.) and crops (Raphanus sativus L., Lactuca sativa L., Lepidium sativum L., Solanum lycopersicum L., Pisum sativum L., and Cucumis sativus L.): both EOs inhibited P. oleracea seed germination, but only E. pulverulenta EO inhibited L. multiflorum radical elongation. Concerning crop species, the investigated EOs showed phytotoxicity in R. sativus.
Specifically, no reports on the phytotoxic activity of these EOs are present in the literature.
Several studies reported the potential herbicidal effect of the constituents of Eucalyptus EOs: Kaur et al. [34] studied the role of monoterpenes in Eucalyptus communities, highlighting the phytotoxicity/allelopathic activity of eucalypt EOs and of their monoterpenes constituents against germination and growth of many crops and weeds, as previously reported by many other authors [34,35,36,37,38].
Kordali et al. [39] investigated the inhibitory effects of monoterpenes on seed germination and seedling growth of different seeds and they concluded that, in general, oxygenated monoterpenes, especially alcohols, showed higher phytotoxic effects in comparison with monoterpene hydrocarbons, thus suggesting a potential use as bio-herbicides. In particular, De Martino et al. [40,41] reported that, between oxygenated monoterpenes, alcohols (borneol, citronellol, geraniol, α-terpineol) appeared as the most inhibitory compounds, followed by ketones (carvone, menthone, camphor) and aldehydes against germination of tested seeds. Alcohols and ketones were the most inhibitory mainly on radish radicle growth and monoterpene alcohol derivatives were more phytotoxic than their acetate derivatives [41]. The herbicidal effect could probably be related to the change in several biochemical and physiological processes, influencing the germination of seeds and/or the elongation of radicle hypocotyl [4]. However, as previously reported in the literature, Eucalyptus EOs can also cause damage to some crops, making it essential to assess their selectivity [4]. It is therefore critical to maximize the herbicidal activity of Eucalyptus against weeds but at the same time to minimize the negative impact on crop growth [2].
Zhou and coworkers [42] studied the phytotoxic and antimicrobial activities of some Eucalyptus essential oils, allowing to hypothesize a possible correlation between these effects. In fact, Khamassi et al. [21] suggested that the application of the essential oils on plant seeds during the germination process could generate oxidative stress, provoking a release of malondialdehyde from fatty acids of membrane phospholipids and so an alteration of membrane integrity, with relative leakage of electrolytes and loss of vital membrane functions. He et al. [43] suggested that when a microbial cell was treated with essential oils, the permeability of its membrane changed, producing a damage to a cell integrity and cell physiological functions.

2.3. Antibiofilm Activity

Table 3 shows the minimal inhibitory concentration of the Eucalyptus EOs necessary to inhibit the bacterial growth of the five pathogens used in our study.
MIC results allowed to evaluate, subsequently, the capacity of the six Eucalyptus EOs to influence the bacterial biofilm and their ability to affect the metabolism of the sessile bacterial cells. Such results could provide more information about the performance of EOs in limiting bacterial virulence which leads to increased bacterial resistance to conventional antibiotics. The results are shown in Table 4 and Table 5, respectively.
As reported in Table 3, the MIC values ranged between 26 and 32 µL/mL. Based on such results, two sub-lethal doses (10 and 20 µL/mL) were used in the antibiofilm tests.
The EOs proved their capacity to effectively inhibit the adhesion process of all five pathogenic tested strains. The inhibition was almost absolute in many cases, with percentages often reaching and exceeding 90% (Table 4). Except for the E. melliodora EO, which inhibited at 25.44% the adhesion of A. baumannii, the other EOs affected the biofilm formation with a powerful inhibitory action provoked by E. transcontinentalis EO (93.99%) and E. odorata EO (92.59%). Exciting results were also obtained by the Eucalyptus EOs against E. coli. In fact, some of these caused an inhibition even superior to 90% (E. paniculata and E. transcontinentalis EOs). The EOs, often already at a dose of 10 µL/mL, showed inhibitory efficacy vs. the bacterial adhesion of more than 80 percent compared to the control.
The experiments on L. monocytogenes (with percentages of inhibition ranging between 59.39 and 90.41%), P. aeruginosa (with inhibition ranges between 51.21 and 91.65%), and S. aureus (48.68–90.19%) indicate that all the EOs were capable of blocking, ab origine, the capacity of this strain to form a biofilm, the first step that leads to the increase of virulence. The anti-biofilm ability exhibited by the Eucalyptus EOs is of particular meaning. The pathogenic bacteria used in our experimentation play a particular role in the food and clinical fields: the common peculiarity was that they were often resistant to antibiotics, or at least increased their resistance due to the inappropriate use of conventional drugs. A. baumannii is widely considered one of the most threatening pathogens on a global scale, particularly in healthcare institutions, being one of the most difficult microorganisms to treat with conventional antibiotics and disinfectants [44]. The A. baumannii bacteremia could cause a significant increase in mortality with respect to other Gram-negative organisms [45]. It has been one of the “red alert” pathogenic bacteria that critically compromise the benefit of the presently applied antibacterial agents [46]. E. coli O157:H7 presents a legitimate concern for the public health [47], found in several foodstuffs, including milk and derivatives, meat and meat products, fruits and derivatives and green salads [48]. P. aeruginosa is a common Gram-negative able to adapt to adverse environments. It is capable of causing disease in humans, plants, and animals. Its connection with serious illnesses, especially hospital-acquired infections, indicated the difficulty of fighting such microorganism with standard drugs, also due to its capacity to form a biofilm [49]. Studies indicated that L. monocytogenes is the only species of the genus involved in known food-borne outbreaks of listeriosis, causing 10 to 40% mortality in patients [50]. S. aureus is an opportunistic pathogen, cause of nosocomial infections with high morbidity and mortality rates [51]. These aspects are also linked to its capacity to secrete multiple toxins and exoenzymes [52], and also to its ability to form biofilm [53]. These characteristics, together with its high multidrug resistance [54], determine a high degree of S. aureus pathogenicity.
The inhibitory activity exhibited by these EOs confirmed previous studies on these bacteria [21,55,56]. On the other hand, for first time, such powerful inhibitory effects have been noted on a range of Gram-negative and Gram-positive pathogens. This indicates that, while generally the non-specific resistance or sensitivity of the bacteria could be also depending on whether they are Gram-positive or Gram-negative bacteria [57], our results have indeed highlighted a wide potential applicability of these EOs. For example, the E. transcontinentalis EO, already at a dose of 10 µL/mL, caused an inhibition of not less than 79% (vs. E. coli) reaching 91.50% (vs. A. baumanni).
Comparing the ability of the Eucalyptus EOs to inhibit the adhesion process with the ability, in some ways even more important, to act on sessile cells present in the mature biofilm (thus capable of exhibiting even more pronounced virulence and more difficult to eradicate), the inhibitory efficacy was maintained, reaching inhibition percentages as high as 93.63 and 91.14% (E. paniculata EO vs. L. monocytogenes and P. aeruginosa, respectively). In some cases, an increase in inhibitory efficacy was evident: for example, E. melliodora EO increased its inhibitory capacities on mature A. baumannii biofilm from 25.44 to 36.37%. In each case, the inhibition was never less than 28.50%. This confirmed the inhibitory activity of the Eucalyptus EOs on the mature biofilm of different pathogens, including those used here, as indicated by other researches with the EOs of different Eucalyptus species [58,59,60,61].
As indicated in Table 4 and Table 5, the inhibitory effect of the Eucalyptus EOs could be ascribable mainly to their influence on the metabolism of the bacterial cell, particularly in the case of the EO of E. odorata. This EO determined an inhibition of the adhesion process of 88.56% and concurrently was capable of affecting the metabolism of the sessile cells at 83.36%. Only when the E. salmonopholia EO was tested against P. aeruginosa, the activity was extremely weak or absent. Therefore, the inhibitory effect of this oil, which produced an inhibition on the immature biofilm at 77.72%, could be due to other mechanisms such as the action on bacterial cells, DNA, bacterial permeabilization system, and others [57]. The effect of the EOs against the sessile cell metabolism within the mature biofilm indicated that often they did not act against the metabolic pathways of the bacterial cells. It happened when E. melliodora EO was added to the mature biofilm of A. baumanni and L. monocytogenes, or when E. odorata EO was administered to the mature biofilm of E. coli, P. aeruginosa, and L. monocytogenes. Again, the biofilm inhibitory action could be triggered by factors other than metabolic ones, also considering the different bacterial physiology in the mature biofilm. With the just mentioned exceptions, the test conducted using MTT showed that the Eucalyptus EOs were capable of acting on sessile cell metabolism even in the mature biofilm, reaching inhibition rates as high as 91.14% (E. paniculata vs. P. aeruginosa), 88.75% (E. paniculata vs. E. coli), and 85.95% (E. paniculata vs. A. baumannii). Furthermore, in all cases when the EOs worked, the inhibition rate never fell below 28.15% (E. odorata vs. L. monocytogenes) and 28.50% (E. melliodora vs. A. baumannii).

3. Materials and Methods

3.1. Plant Material

The leaves of Eucalyptus melliodora, E. paniculata, and E. transcontinentalis were collected at Henchir Naam ( 36.13° N, 9.10° E, 450 m alt.), an upper and middle semi-arid region (Tunisia). E. odorata was collected from Souiniet arboretum (35.54° N, 8.48° E, 492 m alt.), Jendouba, a region characterized by humid climate in the north part of Tunisia. E. bosistoana and E. salmonopholia leaves were collected from Djebel Mansour (36.16° N, 9.42° E), an upper and middle semi-arid region of Tunisia. The plants were identified by Professor Dr. Hamrouni Lamia and voucher specimens of the plants were kept in the herbarium division of the National Institute of Researches on Rural Engineering, Water, and Forests, Tunisia, labelled as EMA2105, EPA2109, ETCS2103, EBO2108, and ESA2102, respectively.

3.2. Extraction of Essential Oils

The leaves collected in April–May 2021 were reduced to fragments and then subjected to hydro-distillation for 3 h as reported in the European Pharmacopoeia [62]. The EOs were dissolved in n-hexane, dried over anhydrous sodium sulfate and kept under N2 at 4 °C in the dark until analysis.

3.3. Analysis of Essential Oils

Analytical gas chromatography was conducted on a Perkin–Elmer Sigma-115 gas chromatograph accessorized with an FID and a data handling processor. The separation was obtained with a HP-5MS fused-silica capillary column (30 m × 0.25 mm i.d., 0.25 μm film thickness). Column temperature: 40 °C, with 5 min initial hold, and then to 270 °C at 2 °C/min, 270 °C (20 min); splitless injection (1 μL of a 1:1000 n-hexane solution). Injector and detector temperatures were 250 °C and 290 °C, respectively. Analysis was also run by using a fused silica HP Innowax polyethylenglycol capillary column (50 m × 0.20 mm i.d., 0.25 μm film thickness). In both cases, He was employed as carrier gas (1.0 mL/min).
GC–MS analyses were conducted with a Hewlett–Packard 5890 A gas chromatograph linked on line to an HP mass selective detector (MSD 5970HP), equipped with a DB-5 fused-silica column (25 m × 0.25 mm i.d.; 0.33 µm film thickness). Ionization energy voltage 70 eV; electron multiplier energy 2000 V. Gas-chromatographic conditions were those described above; transfer line 295 °C.
Most components were identified by comparing their Kovats retention indices with those reported in the literature [63,64] or with those of authentic compounds available in our laboratory. The Kovats retention indices were calculated on the basis of a homologous series of n-alkanes (C10–C35) under the same operating conditions. Further identification was done comparing their mass spectra on both columns with either those present in NIST 02 and Wiley 275 libraries or with the literature [64,65,66], and in a personal library. Components’ relative concentrations were calculated by peak area normalization. Response factors were not considered.

3.4. Phytotoxic Activity

The phytotoxic activity of the EOs was evaluated on germination and root elongation of radish (Raphanus sativus L. cv ‘Saxa’), charlock mustard (Sinapis arvensis L.), and Italian ryegrass (Lolium multiflorum Lam) following the method previously reported [40]. These seeds are histologically well known and they are usually employed in phytotoxic assays for their fast germinability. The seeds were bought from Blumen group srl (Piacenza, Italy); their surface was sterilized in 95% ethanol for 15 s. The seeds were put in Petri dishes (Ø = 90 mm) with five layers of Whatman filter paper, impregnated with distilled water (7 mL, control) or the essential oil solution (7 mL) at different doses. The germination conditions were 20 ± 1 °C with natural photoperiod. The EOs and the pure compounds solubilized in water-acetone mixture (99.5:0.5) were tested at the doses of 1000, 500, 250, 125 µg/mL. No differences between controls performed with water–acetone mixture and controls with water alone were detected. Seed germination was checked directly in Petri dishes every 24 h. A seed was considered germinated when the protrusion of the root became evident [67]. After 120 h, the radicle lengths were measured and expressed in cm. Each determination was replicated three times, using Petri dishes containing 10 seeds each. The results were reported as the mean ± SD for both germination and radicle elongation.

3.5. Antibacterial Activity

3.5.1. Microorganisms and Culture Conditions

Acinetobacter baumannii (ATCC 19606), Escherichia coli (DSM 8579), Pseudomonas aeruginosa (DSM 50071) (Gram-negative), Listeria monocytogenes (ATCC 7644), and Staphylococcus aureus subsp. aureus Rosebach (ATCC 25923) (Gram-positive) were the bacterial strains used in the experiments. Before the microbial analysis, bacteria were cultured in Luria Broth for 18 h at 37 °C (A. baumannii was grown at 35 °C) and 80 rpm (Corning LSE, Pisa, Italy).

3.5.2. Minimal Inhibitory Concentration (MIC)

The resazurin microtiter-plate assay evaluated the MIC [68]. The tests were performed in flat-bottomed 96-well microtiter plates incubated at 37 °C and 35 °C, depending on the strain, for 24 h. The MIC value was revealed by the color change from dark purple to colorless. Determinations were performed in triplicate and results expressed as the mean ± SD.

3.5.3. Biofilm Inhibitory Activity

The capacity of the EOs to influence the bacterial biofilm formation was evaluated in flat-bottomed 96-well microtiter plates (Falcon®, VWR International, Milano, Italy) [69]. Before the test, the overnight bacterial cultures were adjusted to 0.5 McFarland with fresh culture broth. Then, in each well 10 µL of the bacterial cultures, 10 or 20 µL/mL of each EO, and Luria–Bertani broth (LB, Sigma Aldrich Italia, Milano, Italy) were brought to a final volume of 250 µL. Microtiter plates were covered with a parafilm tape to preclude the evaporation of material included in the wells and incubated for 48 h at 37 °C (35 °C for A. baumannii). Following the discard of the planktonic cells, sessile cells were lightly washed twice with sterile phosphate buffered saline (PBS), which was discarded, leaving the plates kept for 10 min under a flow laminar hood. Two hundred µL of methanol were included in each well, leaving it to act for 15 min to permit the fixation of the sessile cells. Methanol was discarded, and each plate was left to dry. The adhered cells were stripped by adding 200 µL of 2% w/v crystal violet solution to each well. After 20 min, the staining solution was discarded, and the plates were lightly washed with sterile PBS and left to dry. The bound dye was released by adding 200 µL of glacial acetic acid 20% w/v. The absorbance was measured at 540 nm (Cary Varian, Milano, Italy). The percent value of adhesion was calculated with respect to the control (formed by the cells grown without the presence of the EOs, for which the inhibition rate was assumed as 0%). Triplicate tests were done, taking the average results for reproducibility, and results were expressed as the mean ± SD.

3.5.4. Inhibition of the Bacterial Metabolism

The effect of EOs on the metabolic activity of the sessile bacterial cells was evaluated through the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric method [69], using 96-well microtiter plates. The overnight bacterial cultures were adjusted to 0.5 McFarland, and the plates with 10 or 20 μl/mL of each EO and LB up to 250 μL were prepared as previously described. After 48 h of incubation in total, bacterial suspension representing the planktonic cells was removed, and 150 µL of PBS and 30 µL of 0.3% MTT (Sigma, Milano, Italy) were added, keeping microplates at 37 °C (35 °C for A. baumannii). The MTT solution was removed after 2 h, and the plates were washed twice with 200 µL of sterile physiological solution. Next, 200 µL of DMSO were added, leading to the formazan crystals’ dissolution, measured at 570 nm (Cary Varian, Milano, Italy) after 2 h. Triplicate tests were done taking the average results for reproducibility, and results were expressed as the mean ± SD.

3.6. Statistical Analysis

All assays were carried out in triplicate. Data of each experiment were expressed as the mean ± SD, and statistically analyzed by two-way ANOVA followed by Dunnett’s multiple comparisons test at the confidence level of 0.05 using GraphPad Prism 6.0 software.

4. Conclusions

The results agree with the previous literature regarding the phytotoxic properties of the Eucalyptus EOs, which could therefore represent an interesting green alternative in the herbicide scenario for use in agriculture. Furthermore, their demonstrated efficacy against the Gram-positive and Gram-negative bacteria used, often resistant to conventional antibiotics, could be related to their ability to decrease bacterial virulence and weaken the mechanisms of bacterial aggression, which is often the cause of the greater difficulty in eradicating the infections they are responsible for. Therefore, the activity exhibited by these Eucalyptus EOs against the pathogens such as P. aeruginosa, S. aureus, E. coli, L. monocytogenes and A. baumannii present in foods, workplaces and hospitals and responsible for several infections could be of considerable importance, both for food and health purposes. Moreover, a suggestive working hypothesis could orient the future research towards a possible link between phytotoxic and antibacterial activities.

Author Contributions

Conceptualization, I.A., L.H. and V.D.F.; methodology, I.A., F.N. and V.D.F.; formal analysis, L.D.M.; investigation, H.K., F.P., F.F., F.N. and Y.M.; resources V.D.F.; data curation F.N., I.A. and F.P.; writing—original draft preparation, F.N., I.A. and F.N.; writing—review and editing, L.H., I.A., F.N., L.D.M. and V.D.F. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data is contend within the article.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Umereweneza, D.; Muhizi, T.; Kamizikunze, T.; Nkurunziza, J.P. Chemical Composition and Antifungal Activity of Essential Oils Extracted from Leaves of Eucalyptus melliodora and Eucalyptus anceps Grown in Rwanda. J. Essent. Oil Bear. Plants 2019, 22, 151–158. [Google Scholar] [CrossRef]
  2. Dhakad, A.K.; Pandey, V.V.; Beg, S.; Rawat, J.M.; Singh, A. Biological, medicinal and toxicological significance of Eucalyptus leaf essential oil: A review. J. Sci. Food Agric. 2018, 98, 833–848. [Google Scholar] [CrossRef]
  3. Dorsaf, B.H.; Hanen, B.I.; Chokri, J.; Larbi Khouja, M.; Manef, A. Chemical composition of some Tunisian Eucalyptus essential oils as obtained by hydrodistillation using clevenger type apparatus. Biosci. Biotechnol. Res. Asia 2010, 7, 647–656. [Google Scholar]
  4. Danna, C.; Cornara, L.; Smeriglio, A.; Trombetta, D.; Amato, G.; Aicardi, P.; De Martino, L.; De Feo, V.; Caputo, L. Eucalyptus gunnii and Eucalyptus pulverulenta ‘Baby Blue’ Essential Oils as Potential Natural Herbicides. Molecules 2021, 26, 6749. [Google Scholar] [CrossRef]
  5. Elaissi, A.; Marzouki, H.; Medini, H.; Larbi Khouja, M.; Farhat, F.; Lynene, F.; Harzallah-Skhiri, F.; Chemli, R. Variation in Volatile Leaf Oils of 13 Eucalyptus Species Harvested from Souinet Arboreta (Tunisia). Chem. Biodivers. 2010, 7, 909–921. [Google Scholar] [CrossRef]
  6. Salehi, B.; Sharifi-Rad, J.; Quispe, C.; Llaique, H.; Villalobos, M.; Smeriglio, A.; Trombetta, D.; Ezzat, S.M.; Salem, M.A.; Zayed, A.; et al. Insights into Eucalyptus genus chemical constituents, biological activities and health-promoting effects. Trends Food Sci. Technol. 2019, 91, 609–624. [Google Scholar] [CrossRef]
  7. Hardel, D.K.; Sahoo, L. A review on phytochemical and pharmacological of Eucalyptus globules: A multipurpose tree. Int. J. Res. Ayurveda Pharm. 2011, 2, 1527–1530. [Google Scholar]
  8. Boland, D.J.; Brooker, M.I.H.; Turnbull, J.W. Eucalyptus Seed; CSIRO Publishing: Collingwood, Australia, 1980. [Google Scholar]
  9. Small, B.E.J. The Australian eucalyptus oil industry—An overview. J. Aust. For. 2013, 44, 170–177. [Google Scholar] [CrossRef]
  10. Bachir, R.G.; Benali, M. Antibacterial activity of the essential oils from the leaves of Eucalyptus globulus against Escherichia coli and Staphylococcus aureus. Asian Pac. J. Trop. Biomed. 2012, 2, 739–742. [Google Scholar] [CrossRef] [Green Version]
  11. Gakuubi, M.M.; Maina, A.W.; Wagacha, J.M. Antifungal activity of essential oil of Eucalyptus camaldulensis Dehnh. against selected Fusarium spp. Int. J. Microbiol. 2017, 2017, 8761610. [Google Scholar] [CrossRef] [Green Version]
  12. Ben Marzoug, H.N.; Romdhane, M.; Lebrihi, A.; Mathieu, F.; Couderc, F.; Abderraba, M.; Larbi Khouja, M.; Bouajila, J. Eucalyptus oleosa essential oils: Chemical composition and antimicrobial and antioxidant activities of the oils from different plant parts (stems, leaves, flowers and fruits). Molecules 2011, 16, 1695–1709. [Google Scholar] [CrossRef]
  13. Valeriano, C.; Oliveira, T.L.C.; Carvalho, S.M.; Cardoso, M.G.; Alves, E.; Piccoli, R.H. The sanitizing action of essential oil-based solutions against Salmonella enterica serotype Enteritidis S64 biofilm formation on AISI 304 stainless steel. Food Control 2012, 25, 673–677. [Google Scholar] [CrossRef]
  14. Ameur, E.; Sarra, M.; Yosra, D.; Mariem, K.; Nabil, A.; Lynen, F.; Larbi, K.M. Chemical composition of essential oils of eight Tunisian Eucalyptus species and their antibacterial activity against strains responsible for otitis. BMC Complement. Med. Ther. 2021, 21, 209. [Google Scholar] [CrossRef]
  15. Pino, J.A.; Marbot, R.; Quert, R.; Garcia, H. Study of essential oils of Eucalyptus resinifera Smith, E. tereticornis Smith and Corymbia maculata (Hook.) K. D. Hill & L. A. S. Johnson, grown in Cuba. Flavour Fragr. J. 2002, 17, 1–4. [Google Scholar] [CrossRef]
  16. Serwecińska, L. Antimicrobials and Antibiotic-Resistant Bacteria: A Risk to the Environment and to Public Health. Water 2020, 12, 3313. [Google Scholar] [CrossRef]
  17. Elaissi, A.; Rouis, Z.; Salem, N.A.; Mabrouk, S.; Ben Salem, Y.; Salah, K.B.; Aouni, M.; Farhat, F.; Chemli, R.; Harzallah-Skhiri, F.; et al. Chemical composition of 8 eucalyptus species’ essential oils and the evaluation of their antibacterial, antifungal and antiviral activities. BMC Complement. Altern. Med. 2012, 12, 81. [Google Scholar] [CrossRef] [Green Version]
  18. Zhang, J.B.; An, M.; Wu, H.; Stanton, R.; Lemerle, D. Eucalyptus essential oils: Chemistry and bioactivity. Allelopathy J. 2010, 25, 313–330. [Google Scholar]
  19. Gilles, M.; Zhao, J.; An, M.; Agboola, S. Chemical composition and antimicrobial properties of essential oils of three Australian Eucalyptus species. Food Chem. 2010, 119, 731–737. [Google Scholar] [CrossRef]
  20. Ghalem, B.R.; Mohamed, B. Antibacterial activity of leaf essential oils of Eucalyptus globulus and Eucalyptus camaldulensis. Afr. J. Pharm. Pharmacol. 2008, 2, 211–215. [Google Scholar]
  21. Khammassi, M.; Polito, F.; Amri, I.; Khedhri, S.; Hamrouni, L.; Nazzaro, F.; Fratianni, F.; De Feo, V. Chemical Composition and Phytotoxic, Antibacterial and Antibiofilm Activity of the Essential Oils of Eucalyptus occidentalis, E. striaticalyx and E. stricklandii. Molecules 2022, 27, 5820. [Google Scholar] [CrossRef]
  22. Raveau, R.; Fontaine, J.; Lounès-Hadj Sahraoui, A. Essential Oils as Potential Alternative Biocontrol Products against Plant Pathogens and Weeds: A Review. Foods 2020, 9, 365. [Google Scholar] [CrossRef] [Green Version]
  23. Setia, N.; Batish, D.R.; Singh, H.P.; Kohli, R.K. Phytotoxicity of volatile oil from Eucalyptus citriodora against some weedy species. J. Environ. Biol. 2007, 28, 63–66. [Google Scholar]
  24. Ramezani, S.; Saharkhiz, M.J.; Ramezani, F.; Fotokian, M.H. Use of essential oils as bioherbicides. J. Essent. Oil Bear. Plants 2008, 11, 319–327. [Google Scholar] [CrossRef]
  25. Holeman, M.; Rombourg, M.; Fechtal, M.; Gorrichon, J.P.; Lassaigne, G. Eucalyptus astringens Maiden, Eucalyptus blakelyi Maiden and Eucalyptus bosistoana F. Muell.: The same chemotype. Plantes Med. Phytother. 1987, 21, 311–316. [Google Scholar]
  26. Bouzabata, A.; Bighelli, A.; Abed, L.; Casanova, J.; Tomi, F. Composition and chemical variability of Eucalyptus bosistoana essential oil from Algerian Sahara. Nat. Prod. Commun. 2014, 9, 701–702. [Google Scholar] [CrossRef] [Green Version]
  27. Zrira, S.S.; Benjilali, B.B. Seasonal Changes in the Volatile Oil and Cineole Contents of Five Eucalyptus Species Growing in Morocco. J. Essent. Oil Res. 1996, 8, 19–24. [Google Scholar] [CrossRef]
  28. Sadeghi, H.; Reza, N.A.; Yoosefi, S. Essential leaf oil and nuclear ribosomal DNA sequence variation in six Eucalyptus populations. J. Essent. Oil Res. 2014, 26, 377–384. [Google Scholar] [CrossRef]
  29. Eid, H.H.; Ibrahim, T.A.; Sleem, A.A. Phytochemical and biological study of essential oils of four Eucalyptus species grown in Egypt. Egypt. J. Biomed. Sci. 2007, 24, 242–259. [Google Scholar]
  30. Elaissi, A.; Salah, K.H.; Mabrouk, S.; Larbi Khouja, M.; Chemli, R.; Harzallah-Skhiri, F. Antibacterial activity and chemical composition of 20 Eucalyptus species’ essential oils. Food Chem. 2011, 129, 1427–1434. [Google Scholar] [CrossRef]
  31. Elaissi, A.; Medini, H.; Rouis, Z.; Larbi Khouja, M.; Chemli, R.; Harzallah-Skhiri, F. Correlation between the chemotaxonomic classifications of the essential oils of 48 Eucalyptus species harvested from Tunisia and their phylogenetic classification. J. Exp. Biol. Agric. Sci. 2014, 2, 98–112. [Google Scholar]
  32. Elaissi, A.; Moumni, S.; Roeleveld, K.; Larbi Khouja, M. Chemical Characterization of Five Tunisian Eucalyptus Essential Oils Species. Chem. Biodivers. 2020, 17, e1900378. [Google Scholar] [CrossRef]
  33. Elaissi, A.; Cheraief, I.; Bannour, F.; Farhat, F.; Ben Salah, M.; Chemli, R.; Larbi Khouja, M. Contribution to the qualitative and quantitative study of seven Eucalyptus species’ essential oil harvested in Hajeb’s Layoun Arboreta (Tunisia). J. Essent. Oil Bear. Plants 2007, 10, 15–25. [Google Scholar] [CrossRef]
  34. Kaur, S.; Singh, H.P.; Batish, D.R.; Kohli, R.K. Role of Monoterpenes in Eucalyptus Communities. Curr. Bioact. Compd. 2012, 8, 101–107. [Google Scholar] [CrossRef]
  35. Batish, D.R.; Singh, H.P.; Setia, N.; Kaur, S.; Kohli, R.K. Chemical composition and inhibitory activity of essential oil from decaying leaves of Eucalyptus citriodora. Z. Naturforsch. 2006, 61, 52–56. [Google Scholar] [CrossRef]
  36. Azizi, M.; Fuji, Y. Allelopathic effect of some medicinal plant substances on seed germination of Amaranthus retroflexus and Portulaca oleracea. Acta Horticult. 2006, 699, 61–68. [Google Scholar] [CrossRef]
  37. Kohli, R.K.; Singh, D. Allelopathic impact of volatile components from Eucalyptus on crop plants. Biol. Plant. 1991, 33, 475–483. [Google Scholar]
  38. Singh, H.P.; Batish, D.R.; Kaur, S.; Ramezani, H.; Kohli, R.K. Comparative phytotoxicity of four monoterpenes against Cassia occidentalis. Ann. Appl. Biol. 2002, 141, 111–116. [Google Scholar] [CrossRef]
  39. Kordali, S.; Cakirb, A.; Sutaya, S. Inhibitory effects of monoterpenes on seed germination and seedling growth. Z. Naturforsch. 2007, 62, 207–214. [Google Scholar] [CrossRef] [Green Version]
  40. De Martino, L.; Mancini, E.; De Almeida, L.F.R.; De Feo, V. The antigerminative activity of twenty-seven monoterpenes. Molecules 2010, 15, 6630–6637. [Google Scholar] [CrossRef]
  41. De Martino, L.; Mancini, E.; Marandino, A.; De Almeida, L.F.; De Feo, V. Chemistry and antigerminative activity ofessential oils and monoterpenoids from Mediterranean plants. Curr. Bioact. Compd. 2012, 8, 13–49. [Google Scholar]
  42. Zhou, L.; Li, J.; Kong, Q.; Luo, S.; Wang, J.; Feng, S.; Yuan, M.; Chen, T.; Yuan, S.; Ding, C. Chemical Composition, Antioxidant, Antimicrobial, and Phytotoxic Potential of Eucalyptus grandis × E. urophylla Leaves Essential Oils. Molecules 2021, 26, 1450. [Google Scholar] [CrossRef]
  43. He, Y.; Sang, S.; Tang, H.; Ou, C. In vitro mechanism of antibacterial activity of eucalyptus essential oil against specific spoilage organisms in aquatic products. J. Food Process. Preserv. 2022, 46, e16349. [Google Scholar] [CrossRef]
  44. Peleg, A.Y.; Seifert, H.; Paterson, D.L. Acinetobacter baumannii: Emergence of a successful pathogen. Clin. Microbiol. Rev. 2008, 21, 538. [Google Scholar] [CrossRef]
  45. Robenshtok, E.; Paul, M.; Leibovici, L.; Fraser, A.; Pitlik, S.; Ostfeld, I.; Samra, Z.; Perez, S.; Lev, B.; Weinberger, M. The significance of Acinetobacter baumannii bacteremia compared with Klebsiella pneumoniae bacteremia: Risk factors and outcomes. J. Hosp. Infect. 2006, 64, 282–287. [Google Scholar] [CrossRef]
  46. Talbot, G.H.; Bradley, J.; Edwards, J.E., Jr.; Gilbert, D.; Scheld, M.; Bartlett, J.G. Bad bugs need drugs: An update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. Clin. Infect. Dis. 2006, 42, 657–668. [Google Scholar] [CrossRef] [Green Version]
  47. Mead, P.S.; Griffin, P.M. Escherichia coli O157:H7. Lancet 1998, 352, 1207–1212. [Google Scholar] [CrossRef]
  48. Buchanan, R.L.; Doyle, M.P. Foodborne disease significance of Escherichia coli O157:H7 and other enterohemorrhagic E. coli. Food Technol. 1997, 51, 69–76. [Google Scholar]
  49. Mulcahy, L.R.; Isabella, V.M.; Lewis, K. Pseudomonas aeruginosa biofilms in disease. Microb. Ecol. 2014, 68, 1–12. [Google Scholar] [CrossRef] [Green Version]
  50. Abdollahzadeh, E.; Rezaei, M.; Hosseini, H. Antibacterial activity of plant essential oils and extracts: The role of thyme essential oil, nisin, and their combination to control Listeria monocytogenes inoculated in minced fish meat. Food Control 2014, 35, 177–183. [Google Scholar] [CrossRef]
  51. Fridkin, S.K.; Hageman, J.C.; Morrison, M.; Sanza, L.T.; Como-Sabetti, K.; Jernigan, J.A.; Harriman, K.; Harrison, L.H.; Lynfield, R.; Farley, M.M. Methicillin-resistant Staphylococcus aureus disease in three communities. N. Engl. J. Med. 2005, 352, 1436–1444. [Google Scholar] [CrossRef]
  52. Prévost, G. Toxins in Staphylococcus aureus pathogenesis. In Microbial Toxins: Molecular and Cellular Biology; Proft, Ed.; Horizon Bioscience: Norfolk, UK, 2005; pp. 243–284. [Google Scholar]
  53. Lentino, J.R. Prosthetic joint infections: Bane of orthopedists, challenge for infectious disease specialists. Clin. Infect. Dis. 2003, 36, 1157–1161. [Google Scholar] [CrossRef]
  54. Lowy, F.D. Antimicrobial resistance: The example of Staphylococcus aureus. J. Clin. Investig. 2003, 111, 1265–1273. [Google Scholar] [CrossRef]
  55. Chaleshtori, F.S.; Saholi, M.; Chaleshtori, R.S. Chemical Composition, Antioxidant and Antibacterial Activity of Bunium persicum, Eucalyptus globulus, and Rose Water on Multidrug-Resistant Listeria Species. J. Evid.-Based Integr. Med. 2018, 23, 2515690X17751314. [Google Scholar] [CrossRef] [Green Version]
  56. Merghni, A.; Noumi, E.; Hadded, O.; Dridi, N.; Panwar, H.; Ceylan, O.; Mastouri, M.; Snoussi, M. Assessment of the antibiofilm and antiquorum sensing activities of Eucalyptus globulus essential oil and its main component 1,8-cineole against methicillin-resistant Staphylococcus aureus strains. Microb. Pathog. 2018, 118, 74–80. [Google Scholar] [CrossRef]
  57. Nazzaro, F.; Fratianni, F.; De Martino, L.; Coppola, R.; De Feo, V. Effect of essential oils on pathogenic bacteria. Pharmaceuticals 2013, 6, 1451–1474. [Google Scholar] [CrossRef]
  58. Iseppi, R.; Di Cerbo, A.; Aloisi, P.; Manelli, M.; Pellesi, V.; Provenzano, C.; Camellini, S.; Messi, P.; Sabia, C. In Vitro Activity of Essential Oils against Planktonic and Biofilm Cells of Extended-Spectrum β-Lactamase (ESBL)/Carbapenamase-Producing Gram-Negative Bacteria Involved in Human Nosocomial Infections. Antibiotics 2020, 9, 272. [Google Scholar] [CrossRef]
  59. Caputo, L.; Smeriglio, A.; Trombetta, D.; Cornara, L.; Trevena, G.; Valussi, M.; Fratianni, F.; De Feo, V.; Nazzaro, F. Chemical Composition and Biological Activities of the Essential Oils of Leptospermum petersonii and Eucalyptus gunnii. Front. Microbiol. 2020, 11, 409. [Google Scholar] [CrossRef] [Green Version]
  60. Lagha, R.; Ben Abdallah, F.; AL-Sarhan, B.O.; Al-Sodany, Y. Antibacterial and Biofilm Inhibitory Activity of Medicinal Plant Essential Oils against Escherichia coli Isolated from UTI Patients. Molecules 2019, 24, 1161. [Google Scholar] [CrossRef] [Green Version]
  61. Al-Qaysi, A.-M.K.; Al-Ouqaili, M.T.S.; Al-Meani, S.A.L. Ciprofloxacin- and gentamicin-mediated inhibition of Pseudomonas aeruginosa biofilms is enhanced when combined the volatile oil from Eucalyptus camaldulensis. Syst. Rev. Pharm. 2020, 11, 98–105. [Google Scholar]
  62. Council of Europe. European Pharmacopoeia, 10th ed.; Council of Europe: Strasbourg, France, 2020. [Google Scholar]
  63. Davies, N.W. Gas chromatographic retention indices of monoterpenes and sesquiterpenes on methyl silicon and Carbowax 20M phases. J. Chromatogr. A 1990, 503, 1–24. [Google Scholar] [CrossRef]
  64. Jennings, W.; Shibamoto, T. Qualitative Analysis of Flavor and Fragrance Volatiles by Glass Capillary Gas Chromatography; Academic Press: New York, NY, USA, 1980. [Google Scholar]
  65. Adams, R.P. Identification of Essential Oil Components by Gas Chromatography/mass Spectrometry, 4th ed.; Allured Publishing Corporation: Carol Stream, IL, USA, 2007. [Google Scholar]
  66. Goodner, K.L. Practical retention index models of OV-101, DB-1, DB-5, and DB-Wax for flavor and fragrance compounds. LWT-Food Sci. Technol. 2008, 41, 951–958. [Google Scholar] [CrossRef]
  67. Bewley, J.D.; Black, M. Seeds: Physiology of Development and Germination, 2nd ed.; Springer: New York, NY, USA, 1994. [Google Scholar]
  68. Sarker, S.D.; Nahar, L.; Kumarasamy, Y. Microtitre plate-based antibacterial assay incorporating resazurin as an indicator of cell growth, and its application in the in vitro antibacterial screening of phytochemicals. Methods 2007, 42, 321–324. [Google Scholar] [CrossRef]
  69. Fratianni, F.; d’Acierno, A.; Ombra, M.N.; Amato, G.; De Feo, V.; Ayala-Zaval, J.F.; Coppola, R.; Nazzaro, F. Fatty acid composition and in vitro anti-inflammatory activity of five cold-pressed Prunus seed oils, and their anti-biofilm effect against pathogenic bacteria. Front. Nutr. 2021, 8, 775751. [Google Scholar] [CrossRef]
Table 1. Chemical composition of the EOs of Eucalyptus bosistoana (Eb), E. melliodora (Em), E. odorata (Eo), E. paniculata (Ep), E. salmonopholia (Es), and E. transcontinentalis (Etr).
Table 1. Chemical composition of the EOs of Eucalyptus bosistoana (Eb), E. melliodora (Em), E. odorata (Eo), E. paniculata (Ep), E. salmonopholia (Es), and E. transcontinentalis (Etr).
KI aKI bCompound EbEmEoEpEsEtrIdentification c
770 n-Octanet-----1,2
8641012α-Pinene1.18.21.51.510.914.81,2,3
8761092Camphenet0.20.1-0.10.11,2,3
8831115Thuja-2,4(10)-dienet-----1,2
9021110β-Pinene--2.53.40.50.41,2,3
9031205Limonenet-----1,2,3
9221145Myrcene-----0.11,2,3
9291177α-Phellandrene--0.2-0.10.11,2,3
9411170α-Terpinene--0.3---1,2,3
9521250a-Cymene--25.41.62.1-1,2,3
9571210Eucalyptol75.278.16.844.970.848.41,2,3
9831221γ-Terpinene-0.20.30.20.10.11,2,3
9961115cis-Sabinene hydrate --0.4---1,2,3
997 cis -Linalool oxide ---0.1--1,2,3
10081291Terpinolene--0.30.5--1,2,3
10101250p-Cymenene --0.6---1,2
10111384α-pinene oxidet-----1,2
10231506Linalool--1.11.3--1,2,3
1029 Pentanoic acid, pentyl ester-0.3--0.70.31,2
1031 exo-Fenchol0.20.6---0.51,2
1032 Isopinocampheol----0.3-1,2
10401474trans-Sabinene hydrate --0.3---1,2
10421485α-Campholenal--1.3--0.11,2
1043 3-Cyclopentene-1-acetaldehyd-0.1----1,2
1044 6-Camphenol ---0.60.10.21,2
1051 Nopinone--0.5---1,2
10521382allo-Ocimene 0.30.1--0.10.11,2,3
10551720trans-Sabinol --3.6---1,2
10561753Cumin aldehyde--2.41.2--1,2
10581664trans-Pinocarveol6.83.8-10.84,310.81,2
1062 cis-Pinene hydrate -0.1----1,2
10631663cis-Verbenolt-----1,2
1065 cis-β-terpineol --0.5--0.11,2
10691643Sabina ketone--7.71.1--1,2
1075 trans-Pinocamphone -----0.11,2
10761468trans-Limonene oxidet-----1,2
10781580Pinocarvone1.30.81.52.81.12.91,2,3
10821715Borneol0.31.21.32.20.20.61,2,3
1084 neo-Iso-isopulegol -0.2----1,2
KI aKI bCompoundEbEmEoEpEsEtrIdentification c
10851832trans-Carveol0.2-----1,2
1086 Menthol----0.1-1,2,3
1087 cis-Pinocamphone -----0.21,2
1092 cis-Pulegolt-----1,2
10931590Terpinen-4-ol-0.441.20.40.41,2,3
10971665neo-Verbanol --7.91.8--1,2
10991678trans-p-Mentha-2,8-dien-1-ol0.9-----1,2
11021661α-Terpineol-3.36.7-0.80.81,2,3
11051828p-Cymen-8-ol--1.7---1,2
1106 cis-Pinocarveol ----0.30.11,2
11071678cis-p-Mentha-2,8-dien-1-ol0.1-----1,2
1108 Myrtenal-----0.51,2
11091661β-terpineol---3.4--1,2,3
1110 Dihydro carveol-0.2-1.2--1,2
11111720trans-Sabinolt-----1,2
11151791Myrtenol---20.5-1,2
1122 trans-Dihydro carvone -----0.21,2
11231726Verbenone---1.5--1,2
11341683trans-Verbenol1.1-----1,2
11421878trans-Carveol --0.5-0.40.21,2
11501581Thymol, methyl ether--7.4---1,2
11671717Citronellol----0.2-1,2,3
11811720p-Menth-1-en-7-al--4.6---1,2
11931491Camphort-----1,2,3
1198 α-Terpinen-7-al ---0.2--1,2
12111868Carvacrol acetate---0.5--1,2
12302172Thymol--2.1-0.7-1,2,3
1247 exo-2-Hydroxycineole acetate ----0.21,2
1248 Car-3-en-2-one0.1-----1,2
1248 γ-Terpinen-7-al ----0.2-1,2
12502219Carvacrol----0.3-1,2
1253 trans-Sabinene hydrate acetatet-----1,2
13271631Aromadendrene----0.10.51,2,3
1332 Presilphiperfol-7-ene0.8-----1,2
1337 Silphinenet-----1,2
1349 Longicyclene0.2-----1,2
1361 α-Ylangenet-----1,2
13741660allo-Aromadendrene -----0.11,2,3
13841725β-Selinene-----0.11,2
13861548β-Cubebene0.1-----1,2,3
1408 Viridiflorene--0.20.1-0.61,2
14331574Longifolenet--0.1--1,2
KI aKI bCompoundEbEmEoEpEsEtrIdentification c
14341957epi-Cubebol ---0.2--1,2
1441 γ-Patchoulene---0.2--1,2
14442096Epiglobulol0.5-----1,2
1448 α-Guaiene0.4-----1,2
14592127Spathulenol--2.44.20.3-1,2
1460 α-Himalachene1.6-----1,2
1462 cis-Eudesma-6,11-diene0.2-----1,2
14642110Viridiflorol--0.85.2-0.21,2
1465 (-)-Globulol----0.5-1,2,3
1466 Patchoulene-----2.91,2
14671722β-Selinene3.5-----1,2
1472 trans-β-Guaiene ---0.1-0.41,2
14731748cis-β-guaiene0.8-----1,2
14741752γ-Cadinene -----0.11,2
1475 10-epi-Cubebol0.3-----1,2
1482 Modhephen-8-β-ol-----0.21,2
1483 allo-Cedrol0.3-----1,2
1495 Rosifoliol0.2----0.21,2
1497 (E)-γ-Bisabolene0.1-----1,2
15012080Cubenol -0.70.7--1,2
15052178γ-Eudesmol ----21,2
1515 β-Eudesmol -0.30.90.84.31,2
15232247α-Eudesmol --1.3-3.31,2
Total96.697.897.997.097.097.2
Monoterpene hydrocarbons1.48.730.36.713.915.7
Oxygentated monoterpenes86.289.062.777.381.466.6
Sesquiterpene hydrocarbons7.700.20.50.14.7
Oxygentated sesquiterpenes 1.304.212.51.610.2
Others0.00.10.50.0000.0
a Kovats index determined relative to the tR of a series of n-alkanes (C10-C35) on a HP-5 MS column; b Kovats index determined relative to the tR of a series of n-alkanes (C10-C35) on HP Innowax; c 1 = retention index reported in literature, 2 = mass spectrum, 3 = co-injection with authentic compound; t = trace <0.05%.
Table 2. Effects of different doses of the EOs on germination (number of germinated seeds) and radical elongation (cm) of Raphanus sativus, Sinapis arvensis and Lolium multiflorum.
Table 2. Effects of different doses of the EOs on germination (number of germinated seeds) and radical elongation (cm) of Raphanus sativus, Sinapis arvensis and Lolium multiflorum.
R. sativus Germination
Dose (µg/mL)E. bosistoanaE. melliodoraE. odorataE. paniculataE. salmonopholiaE. transcontinentalis
Control9.3 ± 1.29.7 ± 0.67.7 ± 0.68.0 ± 1.06.3 ± 1.58.0 ± 1.7
1256.7 ± 1.2 **9.3 ± 1.24.0 ± 1.0 ****0.7 ± 0.6 ****5.3 ± 2.56.3 ± 1.5
2504.7 ± 0.6 ****9.7 ± 0.61.3 ± 0.6 ****0.7 ± 0.6 ****5.7 ± 2.13.7 ± 0.6 ****
5001.3 ± 0.6 ****9.7 ± 0.60.3 ± 0.6 ****0.0 ± 0.0 ****1.7 ± 2.1 ****1.3 ± 1.2 ****
10000.0 ± 0.0 ****6.3 ± 1.5 ****0.0 ± 0.0 ****0.0 ± 0.0 ****0.3 ± 0.6 ****0.0 ± 0.0 ****
R. sativus Radical elongation
Control3.0 ± 0.16.3 ± 0.22.7 ± 0.33.2 ± 0.31.4 ± 0.14.0 ± 0.2
1252.1 ± 0.3 ****6.1 ± 0.41.7 ± 0.2 ****1.0 ± 1.0 ****1.0 ± 0.12.3 ± 0.6 *
2501.6 ± 0.3 ****4.1 ± 0.3 ****0.6 ± 0.1 ****0.4 ± 0.4 ****1.1 ± 0.31.9 ± 0.5 **
5000.6 ± 0.3 ****3.1 ± 0.5 ****0.1 ± 0.1 ****0.0 ± 0.0 ****0.6 ± 0.52.2 ± 2.0 *
10000.0 ± 0.0 ****2.0 ± 0.1 ****0.0 ± 0.0 ****0.0 ± 0.0 ****0.1 ± 0.2 *0.0 ± 0.0 ****
S. arvensis Germination
Dose (µg/mL)E. bosistoanaE. melliodoraE. odorataE. paniculataE. salmonopholiaE. transcontinentalis
Control10.0 ± 0.010.0 ± 0.09.7 ± 0.69.7 ± 0.610.0 ± 0.010.0 ± 0.0
1259.3 ± 0.69.0 ± 1.00.0 ± 0.0 ****1.7 ± 0.6 ****9.7 ± 0.69.7 ± 0.6
2504.0 ± 1.0 ****5.3 ± 1.2 ****0.0 ± 0.0 ****0.3 ± 0.6 ****6.7 ± 1.5 *5.3 ± 1.5 ****
5001.0 ± 1.0 ****1.3 ± 0.6 ****0.0 ± 0.0 ****0.0 ± 0.0 ****0.7 ± 0.6 ****1.0 ± 1.7 ****
10000.0 ± 0.0 ****0.3 ± 0.6 ****0.0 ± 0.0 ****0.0 ± 0.0 ****0.0 ± 0.0 ****0.0 ± 0.0 ****
S. arvensis Radical elongation
Control3.8 ± 0.16.5 ± 0.66.7 ± 0.23.9 ± 0.13.8 ± 0.83.8 ±0.8
1251.3 ± 0.1 ****2.4 ± 0.7 ****0.0 ± 0.0 ****0.8 ± 0.1 ****2.5 ± 0.0 *1.9 ± 0.7 **
2500.6 ± 0.2 ****1.2 ± 0.3 ****0.0 ± 0.0 ****0.1 ± 0.2 ****1.4 ± 0.4 ****0.5 ± 0.2 ****
5000.7 ± 0.6 ****0.7 ± 0.4 ****0.0 ± 0.0 ****0.0 ± 0.0 ****0.6 ± 0.7 ****0.4 ± 0.6 ****
10000.0 ± 0.0 ****0.1 ± 0.2 ****0.0 ± 0.0 ****0.0 ± 0.0 ****0.0 ± 0.0 ****0.0 ± 0.0 ****
L. multiflorum Germination
E. bosistoanaE. melliodoraE. odorataE. paniculataE. salmonopholiaE. transcontinentalis
Control9.3 ± 0.68.3 ± 0.68.7 ± 1.29.3 ± 0.69.7 ± 0.69.7 ± 0.6
1259.0 ± 1.08.0 ± 1.07.3 ± 1.29.0 ± 1.09.7 ± 0.68.7 ± 0.6
2508.7 ± 1.28.0 ± 1.06.3 ± 0.6 ****8.7 ± 0.68.3 ± 0.68.0 ± 1.7
5008.3 ± 0.67.3 ± 1.23.7 ± 0.6 ****5.3 ± 0.6 ****9.3 ± 0.68.0 ± 1.0
10004.7 ± 0.6 ****6.3 ± 0.60.0 ± 0.0 ****0.0 ± 0.0 ****7.7 ± 0.61.0 ± 1.0 ****
L. multiflorum Radical elongation
Control4.7 ± 0.26.5 ± 0.25.4 ± 0.64.9 ± 0.25.1 ± 0.65.5 ± 0.3
1253.2 ± 0.1 ****3.8 ± 0.3 ****1.6 ± 0.4 ****2.7 ± 0.3 ****5.5 ± 0.52.7 ± 0.2 ****
2502.0 ± 0.2 ****2.7 ± 0.2 ****0.7 ± 0.3 ****1.2 ± 0.2 ****4.2 ± 0.71.6 ± 0.3 ****
5000.9 ± 0.1 ****1.3 ± 0.3 ****0.3 ± 0.1 ****0.3 ± 0.1 ****3.5 ± 0.5 **0.4 ± 0.2 ****
10000.5 ± 0.2 ****0.5 ± 0.3 ****0.0 ± 0.0 ****0.0 ± 0.0 ****0.8 ± 0.3 ****0.1 ± 0.1 ****
Results are reported as the mean ± SD of three experiments. * p < 0.05, ** p < 0.01, **** p < 0.0001 vs. control, according to a two-way ANOVA followed by Dunnett’s post-hoc test.
Table 3. MIC (µL/mL) of the Eucalyptus EOs required to inhibit the growth of A. baumannii, E. coli, L. monocytogenes, P. aeruginosa and S. aureus. Tetracycline was used as a positive control.
Table 3. MIC (µL/mL) of the Eucalyptus EOs required to inhibit the growth of A. baumannii, E. coli, L. monocytogenes, P. aeruginosa and S. aureus. Tetracycline was used as a positive control.
MIC (µL/mL)
A. baumanniiE. coliL. monocytogenesP. aeruginosaS. aureus
E. bosistoana27 ± 226 ± 2 *28 ± 228 ± 124 ± 2
E. melliodora30 ± 1 *24 ± 130 ± 1 *28 ±128 ± 1
E. odorata28 ± 126 ± 1 *30 ± 1 *27 ± 127 ± 1
E. paniculata26 ± 226 ± 1 *28 ± 130 ± 2 *28 ± 1
E. salmonopholia30 ± 1 *28 ± 1 ****30 ± 1 *30 ± 1 *32 ± 1 ****
E. transcontinentalis28 ± 126 ± 1 *26 (±1)28 ± 128 ± 1
Tetracycicline 27 ± 1 23 ± 127 (±2)26 ± 226 ± 1
Data are expressed as the mean ± SD of three experiments. * p < 0.05; **** p < 0.0001 vs. Tetracycline according to a two-way ANOVA followed by Dunnett’s post-hoc test.
Table 4. Percent inhibition of bacterial biofilm formation caused by the addition of the Eucalyptus EOs at 0 and 24 h.
Table 4. Percent inhibition of bacterial biofilm formation caused by the addition of the Eucalyptus EOs at 0 and 24 h.
Time 0A. baumanniiE. coliL. monocytogenesP. aeruginosaS. aureus
E. bosistoana
10 µL/mL
59.40 ±
0.60 ****
68.52 ±
0.30 ****
57.71 ±
0.22 ****
63.26 ±
0.15 ****
65.76 ±
0.09 ****
E. bosistoana
20 µL/mL
76.69 ±
0.28 ****
78.83 ±
0.22 ****
58.77 ±
0.18 ****
74.77 ±
0.14 ****
69.39 ±
0.15 ****
E. melliodora
10 µL/mL
8.93 ±
0.78 ****
13.39 ±
0.64 ****
59.39 ±
0.22 ****
51.21 ±
0.29 ****
73.87 ±
0.08 ****
E. melliodora
20 µL/mL
25.44 ±
0.38 ****
30.35 ±
0.20 ****
73.31 ±
0.23 ****
60.28 ±
0.16 ****
76.40 ±
0.09 ****
E. odorata
10 µL/mL
88.56 ±
0.14 ****
86.26 ±
0.19 ****
78.83 ±
0.19 ****
75.39 ±
0.18 ****
82.48 ±
0.07 ****
E. odorata
20 µL/mL
92.59 ±
0.27 ****
88.09 ±
0.20 ****
79.57 ±
0.14 ****
77.72 ±
0.15 ****
85.77 ±
0.05 ****
E. paniculata
10 µL/mL
89.63 ±
2.51 ****
87.63 ±
2.45 ****
89.71 ±
1.03 ****
90.93 ±
0.58 ****
85.35 ±
0.76 ****
E. paniculata
20 µL/mL
93.01 ±
0.62 ****
90.89 ±
0.32 ****
91.65 ±
1.15 ****
93.50 ±
0.97 ****
87.02 ±
0.49 ****
E. salmonopholia
10 µL/mL
59.10 ±
0.15 ****
79.22 ±
0.08 ****
67.97 ±
0.20 ****
72.51 ±
0.11 ****
48.68 ±
2.06 ****
E. salmonopholia
20 µL/mL
66.06 ±
0.09 ****
85.00 ±
0.09 ****
69.88 ±
0.05 ****
81.41 ±
0.13 ****
58.45 ±
0.16 ****
E. transcontinentalis
10 µL/mL
91.50 ±
0.11 ****
79.69 ±
0.16 ****
89.25 ±
0.06 ****
83.74 ±
0.04 ****
87.72 ±
0.05 ****
E. transcontinentalis
20 µL/mL
93.99 ±
0.10 ****
91.02 ±
0.07 ****
90.40 ±
0.12 ****
83.89 ±
0.08 ****
90.19 ±
0.18 ****
Time 24 h
E. bosistoana
10 µL/mL
39.70 ±
1.11 ****
39.23 ±
0.83 ****
17.69 ±
2.00 ****
45.62 ±
1.37 ****
78.63 ±
0.50 ****
E. bosistoana
20 µL/mL
58.01 ±
1.14 ****
61.40 ±
0.80 ****
46.21 ±
1.63 ****
60.36 ±
0.75 ****
79.84 ±
0.24 ****
E. melliodora
10 µL/mL
28.50 ±
0.54 ****
39.56 ±
0.37 ****
35.73 ±
0.68 ****
40.66 ±
0.75 ****
75.06 ±
0.04 ****
E. melliodora
20 µL/mL
36.37 ±
1.71 ****
46.42 ±
0.91 ****
37.44 ±
1.13 ****
56.57 ±
0.70 ****
80.01 ±
0.34 ****
E. odorata
10 µL/mL
56.52 ±
0.71 ****
33.71 ±
1.27 ****
28.15 ±
0.88 ****
49.83 ±
0.82 ****
80.05 ±
0.20 ****
E. odorata
20 µL/mL
59.10 ±
0.69 ****
58.53 ±
0.94 ****
33.73 ±
0.65 ****
54.66 ±
1.65 ****
80.63 ±
0.30 ****
E. paniculata
10 µL/mL
83.02 ±
2.27 ****
86.21 ±
2.54 ****
89.47 ±
1.71 ****
89.42 ±
0.61 ****
78.27 ±
0.76 ****
E. paniculata
20 µL/mL
85.95 ±
2.93 ****
88.75 ±
1.84 ****
93.63 ±
1.09 ****
91.14 ±
0.62 ****
85.38 ±
0.96 ****
E. salmonopholia
10 µL/mL
30.79 ±
1.83 ****
9.11 ±
0.91 ****
54.59 ±
0.60 ****
62.44 ±
0.69 ****
49.62 ±
0.33 ****
E. salmonopholia
20 µL/mL
51.03 ±
0.76 ****
62.63 ±
1.44 ****
63.61 ±
0.37 ****
64.50 ±
0.64 ****
53.76 ±
0.29 ****
E. transcontinentalis
10 µL/mL
38.45 ±
0.27 ****
27.15 ±
0.50 ****
40.29 ±
0.36 ****
60.57 ±
0.61 ****
79.55 ±
0.31 ****
E. transcontinentalis
20 µL/mL
47.47 ±
0.43 ****
46.80 ±
0.91 ****
41.69 ±
0.53 ****
60.63 ±
0.63 ****
81.29 ±
0.25 ****
Data are expressed as the mean ± SD of three experiments. **** p < 0.0001 vs. control (0% of inhibition) according to a two-way ANOVA followed by Dunnett’s post-hoc test.
Table 5. Percent of inhibition on sessile cell’s metabolism induced by the presence of the EOs added at the beginning of the bacterial growth (time zero) and after 24 h.
Table 5. Percent of inhibition on sessile cell’s metabolism induced by the presence of the EOs added at the beginning of the bacterial growth (time zero) and after 24 h.
Time 0A. baumanniiE. coliL. monocytogenesP. aeruginosaS. aureus
E. bosistoana
10 µL/mL
80.38 ±
1.48 ****
48.90 ±
1.96 ****
39.63 ±
2.20 ****
72.41 ±
2.17 ****
29.93 ±
0.92 ****
E. bosistoana
20 µL/mL
83.99 ±
0.81 ****
79.52 ±
1.83 ****
73.01 ±
2.20 ****
78.49 ±
0.77 ****
80.94 ±
1.85 ****
E. melliodora
10 µL/mL
66.85 ±
0.51 ****
0.00 ±
0.00 ns
77.69 ±
1.04 ****
70.89 ±
2.91 ****
78.41 ±
1.18 ****
E. melliodora
20 µL/mL
70.01 ±
0.75 ****
0.00 ±
0.00 ns
79.78 ±
0.28
75.46 ±
1.29 ****
80.71 ±
0.79
E. odorata
10 µL/mL
83.36 ±
0.67 ****
75.29 ±
1.48 ****
80.04 ±
1.28 ****
79.72 ±
1.18 ****
79.03 ±
2.67 ****
E. odorata
20 µL/mL
85.12 ±
0.70 ****
78.23 ±
3.98 ****
83.22 ±
0.97 ****
81.93 ±
0.37 ****
81.77 ±
0.30 ****
E. paniculata
10 µL/mL
50.43 ±
6.88 ****
68.65 ±
0.47 ****
76.13 ±
0.52 ****
69.05 ±
1.26 ****
81.24 ±
0.97 ****
E. paniculata
20 µL/mL
63.85 ±
4.11 ****
34.75 ±
0.89 ****
84.69 ±
0.22 ****
81.83 ±
1.42 ****
86.75 ±
1.65 ****
E. salmonopholia
10 µL/mL
0.00 ±
0.00 ns
0.00 ±
0.00 ns
64.05 ±
2.437 ****
0.00 ±
0.00 ns
48.08 ±
0.63 ****
E. salmonopholia
20 µL/mL
46.81 ±
2.00 ****
22.36 ±
1.88 ****
73.40 ±
1.30 ****
10.88 ±
2.09 ****
58.49 ±
0.63 ****
E. transcontinentalis
10 µL/mL
48.03 ±
3.60 ****
48.58 ±
1.76 ****
68.64 ±
1.84 ****
76.88 ±
2.60 ****
85.57 ±
1.35 ****
E. transcontinentalis
20 µL/mL
86.62 ±
2.14 ****
83.74 ±
3.00 ****
88.49 ±
1.73 ****
76.47 ±
3.08 ****
90.61 ±
1.83 ****
Time 24 h
E. bosistoana
10 µL/mL
2.10 ±
1.75 ns
33.53 ±
0.39 ****
29.90 ±
1.09 ****
0.00 ±
0.00 ns
30.89 ±
1.52 ****
E. bosistoana
20 µL/mL
35.07 ±
1.51 ****
51.35 ±
0.92 ****
54.04 ±
0.88 ****
7.09 ±
0.44 ****
33.23 ±
0.52 ****
E. melliodora
10 µL/mL
0.00 ±
0.00 ns
16.49 ±
0.80 ****
0.00 ±
0.00 ns
4.17 ±
0.38 **
8.67 ±
0.68 ****
E. melliodora
20 µL/mL
0.00 ±
0.00 ns
38.93 ±
0.86 ****
0.00 ±
0.00 ns
17.09 ±
1.19 ****
18.98 ±
0.42 ****
E. odorata
10 µL/mL
0.00 ±
0.00 ns
20.60 ±
0.00 ****
0.00 ±
0.00 ns
0.00 ±
0.00 ns
7.95 ±
1.09 ****
E. odorata
20 µL/mL
0.00 ±
0.00 ns
58.69 ±
0.00 ****
0.00 ±
0.00 ns
0.00 ±
0.00 ns
28.29 ±
1.05 ****
E. paniculata
10 µL/mL
50.43 ±
6.88 ****
68.65 ±
0.47 ****
76.13 ±
0.52 ****
69.05 ±
1.26 ****
81.24 ±
0.97 ****
E. paniculata
20 µL/mL
63.85 ±
4.11 ****
34.75 ±
0.89 ****
84.69 ±
0.22 ****
81.83 ±
1.42 ****
86.75 ±
1.65 ****
E. salmonopholia
10 µL/mL
37.30 ±
0.52 ****
52.61 ±
0.45 ****
54.76 ±
0.47 ****
55.14 ±
0.80 ****
25.44 ±
1.74 ****
E. salmonopholia
20 µL/mL
39.33 ±
0.68 ****
72.10 ±
0.51 ****
56.57 ±
0.87 ****
60.74 ±
0.91 ****
58.72 ±
2.46 ****
E. transcontinentalis
10 µL/mL
60.94 ±
0.93 ****
67.46 ±
0.75 ****
57.14 ±
0.44 ****
66.75 ±
0.58 ****
42.86 ±
2.96 ****
E. transcontinentalis
20 µL/mL
65.08 ±
0.48 ****
70.81 ±
0.41 ****
60.60 ±
1.37 ****
72.90 ±
0.81 ****
55.87 ±
1.61 ****
Data are expressed as the mean ± SD of three experiments. ns: not significative; ** p < 0.01; **** p < 0.0001 vs. control (0% of inhibition) according to a two-way ANOVA followed by Dunnett’s post-hoc test.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kouki, H.; Polito, F.; De Martino, L.; Mabrouk, Y.; Hamrouni, L.; Amri, I.; Fratianni, F.; De Feo, V.; Nazzaro, F. Chemistry and Bioactivities of Six Tunisian Eucalyptus Species. Pharmaceuticals 2022, 15, 1265. https://doi.org/10.3390/ph15101265

AMA Style

Kouki H, Polito F, De Martino L, Mabrouk Y, Hamrouni L, Amri I, Fratianni F, De Feo V, Nazzaro F. Chemistry and Bioactivities of Six Tunisian Eucalyptus Species. Pharmaceuticals. 2022; 15(10):1265. https://doi.org/10.3390/ph15101265

Chicago/Turabian Style

Kouki, Habiba, Flavio Polito, Laura De Martino, Yassine Mabrouk, Lamia Hamrouni, Ismail Amri, Florinda Fratianni, Vincenzo De Feo, and Filomena Nazzaro. 2022. "Chemistry and Bioactivities of Six Tunisian Eucalyptus Species" Pharmaceuticals 15, no. 10: 1265. https://doi.org/10.3390/ph15101265

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop